OPU
XENT

Omni Partners US’s Intersect ENT, Inc XENT Stock Holding History

Omni Partners US’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$12.4M Buy
+456,396
New +$11.3M 0.64% 22

Other funds holding XENT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Omni Partners US's XENT Position: Q3 2021 in Review

Omni Partners US opened a new position in Intersect ENT, Inc (XENT) in Q3 2021: 456,396 shares worth $12.4M. The stake represents 0.64% of the portfolio and ranks #22 among its holdings.

123 funds tracked by Wall St. Rank hold XENT as of Q3 2021.

  • Omni Partners US held 456,396 shares of Intersect ENT, Inc worth $12.4M as of Q3 2021.
  • Intersect ENT, Inc was a new Omni Partners US position in Q3 2021.
  • Intersect ENT, Inc made up 0.64% of Omni Partners US's portfolio in Q3 2021, its #22 holding.
  • 123 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q3 2021.

Based on Omni Partners US's 13F filing for Q3 2021, filed 15 Nov 2021.